Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study-Reference-Cited by-同舟云学术

Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study

Published:2023-11 Issue:11 Volume:33 Page:2294-2305
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Candido Riccardo,Nicolucci Antonio^ORCID,Larosa Monica,Rossi Maria Chiara^ORCID,Napoli Raffaele,Gabellieri Enrico,Tortato Elena,Rabini Rosa Anna,Crazzolara Dalia,Lucibelli Luigi,Aragiusto Concetta,Panzolato Gianluigi,Di Mauro Maurizio,Del Buono Andrea,Placentino Giuseppe,Di Cianni Graziano,Brandoni Gabriele,Fazion Stefano,Gregori Giovanna,Di Benedetto Antonino,De Riva Carlo,Terracciano Annamaria,Napoli Raffaele,Zenari Luciano,Placentino Giuseppe,Cavalot Franco,Porcellati Francesca,Anichini Roberto,Citro Giuseppe,D'Angelo Paola,Arca Marcello,Morviducci Lelio,Rabini Rosa Anna,Montani Valeria,Lucibelli Luigi,Placentino Giuseppe,Fiorentini Paolo

Funder

Sanofi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference35 articles.

1. GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: a systematic review and meta-analysis;Castellana;Diabetes Metab Res Rev,2019

2. A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials;Aroda;Diabetes Obes Metabol,2018

3. The cardiovascular biology of glucagon-like peptide-1;Drucker;Cell Metabol,2016

4. Basal insulin and cardiovascular and other outcomes in dysglycemia;Gerstein;N Engl J Med,2012

5. Clinical perspectives from the BEGIN and EDITION programmes: trial-level meta-analyses outcomes with either degludec or glargine 300U/mL vs glargine 100U/mL in T2D;Roussel;Diabetes Metab,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Treatment intensification following glucagon‐like peptide‐1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE‐G real‐world study;Diabetes, Obesity and Metabolism;2024-06-10

3. Solvent effects, chemical reactivity, docking and antimicrobial activity of silver and gold nanocages glimepiride: Experimental and theoretical calculations;Chemical Physics Impact;2024-06

4. Open questions on basal insulin therapy in T2D: a Delphi consensus;Acta Diabetologica;2024-05-20

5. What Is the Role of Basal Weekly Insulin in Clinical Practice? The State of the Art;Biomedicines;2024-04-18